| Issue Date | Title | Author(s) |
| Mar-2021 | Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I & ndash;IIIA non-small cell lung cancer patients | Jia, Bo; Zheng, Qiwen; Li, Jianjie; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Yang, Xue; Chen, Hanxiao; Chi, Yujia; Wang, Jingjing; Zhai, Xiaoyu; He, Yuling; Kong, Lingdong; Wang, Ziping |
| Feb-2021 | Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification | Jia, Bo; Zhao, Xinghui; Wu, Di; Dong, Zhi; Chi, Yujia; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Chen, Xiaoling; Tian, Guangming; Long, Jieran; Yang, Xue; Chen, Hanxiao; Wang, Jingjing; Zhai, Xiaoyu; Li, Sheng; Li, Junfeng; Ma, Menglei; He, Yuling; Kong, Lingdong; Brcic, Luka; Fang, Jian; Wang, Ziping |
| 24-Aug-2020 | Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis | Li, Jianjie; Zheng, Qiwen; Zhao, Xinghui; Zhao, Jun; An, Tongtong; Wu, Meina; Wang, Yuyan; Zhuo, Minglei; Zhong, Jia; Yang, Xue; Jia, Bo; Chen, Hanxiao; Dong, Zhi; Wang, Jingjing; Chi, Yujia; Zhai, Xiaoyu; Wang, Ziping |
| 17-Jul-2020 | A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database | Jia, Bo; Zheng, Qiwen; Wang, Jingjing; Sun, Hongyan; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Yang, Xue; Zhong, Jia; Chen, Hanxiao; Chi, Yujia; Zhai, Xiaoyu; Wang, Ziping |
| 2019 | Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis | Zhong, Jia; Zheng, Qiwen; An, Tongtong; Zhao, Jun; Wu, Meina; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Zhao, Xinghui; Yang, Xue; Jia, Bo; Chen, Hanxiao; Dong, Zhi; Wang, Jingjing; Chi, Yujia; Zhai, Xiaoyu; Wang, Ziping |
| Jan-2021 | Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients | Wang, Yida; Chen, Hanxiao; Zhang, Tianzhuo; Yang, Xue; Zhong, Jia; Wang, Yuyan; Chi, Yujia; Wu, Meina; An, Tongtong; Li, Jianjie; Zhao, Xinghui; Dong, Zhi; Wang, Ziping; Zhao, Jun; Zhuo, Minglei; Huang, Jing |
| Apr-2022 | The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer | Chen, Hanxiao; Huang, Dingzhi; Lin, Gen; Yang, Xue; Zhuo, Minglei; Chi, Yujia; Zhai, Xiaoyu; Jia, Bo; Wang, Jingjing; Wang, Yuyan; Li, Jianjie; An, Tongtong; Wu, Meina; Wang, Ziping; Zhao, Jun |
| May-2020 | Retrospective analysis of the effectiveness and tolerability of nab-paclitaxel in Chinese elderly patients with advanced non-small-cell lung carcinoma | Wang, Shuhang; Liang, Qiuping; Chi, Yujia; Zhuo, Minglei; An, Tongtong; Duan, Jianchun; Wang, Zhijie; Wang, Yuyan; Zhong, Jia; Yang, Xue; Chen, Hanxiao; Wang, Jie; Zhao, Jun |
| 2019 | Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database | Zhuo, Minglei; Zheng, Qiwen; Chi, Yujia; Jia, Bo; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Li, Jianjie; Zhao, Xinghui; Yang, Xue; Zhong, Jia; Chen, Hanxiao; Dong, Zhi; Wang, Jingjing; Zhai, Xiaoyu; Wang, Ziping |
| 2019 | Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis | Jia, Bo; Zheng, Qiwen; Qi, Xinmeng; Zhao, Jun; Wu, Meina; An, Tongtong; Wang, Yuyan; Zhuo, Minglei; Li, Jianjie; Zhao, Xinghui; Yang, Xue; Zhong, Jia; Chen, Hanxiao; Dong, Zhi; Shi, Youwu; Du, Feng; Wang, Jingjing; Chi, Yujia; Zhai, Xiaoyu; Wang, Ziping |
